Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

(d) On July 9, 2009, the Board of Directors of NPS Pharmaceuticals, Inc. (the "Company") elected Colin Broom M.D. as a director to fill a vacancy on the Board. The Company's press release announcing Dr. Broom's election, which is attached as Exhibit 99.1, is incorporated by reference herein. Dr. Broom, 53, currently serves as Vice President, Chief Scientific Officer of ViroPharma Incorporated, a position he has held since May 2004.

In connection with Dr. Broom's election, the Compensation Committee of the Board approved a grant of 36,000 options to Dr. Broom under the Company's 2005 Omnibus Equity Plan. The options will vest over four years and become exercisable 25% on the first anniversary of the date of grant and 6.25% every three months thereafter. Dr. Broom will also participate in the Company's non-employee director compensation program.

Dr. Broom has been appointed to serve on the Audit Committee and the Compensation Committee. There are no arrangements or understandings between Dr. Broom and any other person pursuant to which Dr. Broom was selected as a director. In addition, the Company is not aware of any transaction requiring disclosure herein pursuant to Item 404(a) of Regulation S-K.

ITEM 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Press Release of NPS Pharmaceuticals, Inc. dated July 13, 2009.

---